Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells
2013 ◽
Vol 133
(9)
◽
pp. 2089-2101
◽
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
2020 ◽
Vol 83
(1)
◽
pp. 118-126
◽
Keyword(s):
1997 ◽
Vol 240
(3)
◽
pp. 606-611
◽
Keyword(s):
2016 ◽
Vol 79
(4)
◽
pp. 1097-1104
◽
2012 ◽
Vol 18
(21)
◽
pp. 5934-5948
◽
Keyword(s):